2m 2m 2m 2m 2m 2m 2m
HEMAB THERAP (COAG)
NASDAQ
$37.96-$1.37 (-3.49%)
Price as of Nov 12, 2026 9:55 AM EST- $1.8BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
HEMAB THERAP (COAG)
$37.96-$1.37 (-3.49%)
COAG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $39.33 | ||
Change | +$0.56 (+1.44%) | ||
Open | $38.77 | ||
High | $40.92 | ||
Low | $36.07 | ||
Previous Close | $38.77 | ||
Volume | 655,782 | ||
30-Day Average Volume | 487,043 | ||
1-Week Change | -12.77% | ||
1-Month Change | 24.38% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 46.7M | ||
Total Assets | $442.7M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$27.3M | ||
Free Cash Flow | -$28.3M | ||
EBIT | -$26.6M | ||
EBITDA | -$26.5M | ||
Net Working Capital | $425.2M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -60 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -68 | ||
PEG | -2 | ||
Price/Free Cash Flow | -65 | ||
Price/Operating Cash Flow | -65 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||